Toyobo : Presentation to Investors for the First Quarter Ended June 30, 2021
August 05, 2021 at 12:06 am EDT
Share
August 5, 2021
Presentation to Investors
for the First Quarter Ended June 30, 2021
TOYOBO CO., LTD.
Highlights
Q1 FY 3/22 Results
Despite the impact of rising raw material and fuel prices, sales and profit increased as industrial films and reagents for PCR testing performed strongly and automobile-related demand recovered.
Operating profit of ¥9.2 bn (2.1-fold) and profit of ¥6.2 bn (3.5-fold)
Net sales
+25.4%
(¥ bn.)
75.5
94.6
Q1 FY 3/21
Q1 FY 3/22
FY 3/22 Forecasts
Operating profit
+112%
9.2
4.4
Q1 FY 3/21
Q1 FY 3/22
Profit attributable to
owners of parent
250%
6.2
1.8
Q1 FY 3/21
Q1 FY 3/22
Operating profit was revised upward to ¥29.0 bn as industrial films and reagents for
PCR testing performed strongly despite concerns regarding the impact of rising
raw material and fuel prices. Net profit is forecasted to be ¥13.0 bn.
*(Interest-bearing debt - Cash and deposits)/Shareholder's equity
5
This is an excerpt of the original content. To continue reading it, access the original document here.
Attachments
Original document
Permalink
Disclaimer
Toyobo Co. Ltd. published this content on 05 August 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 05 August 2021 04:05:04 UTC.
Toyobo Co Ltd is a Japan-based company mainly engaged in the film and functional resin business, industrial material business, and textile and commerce business. It has five business segments. Film and Functional Resin segment manufactures, processes and sells packaging films, industrial films, industrial adhesives, engineering plastics and optical functional materials. Industrial Materials segment manufactures, processes and sells automotive fiber materials, super fibers, non-woven fabrics. Textile and Trading segment manufactures and sells functional clothing, apparel products, clothing textiles, and clothing fibers. Healthcare segment manufactures, processes and sells bio products, pharmaceuticals, medical membranes, medical devices, aqua membranes, and functional filters. It is also engaged in the assembly and sale of seawater desalination modules. The Real Estate segment sells, rents and manages movables. It also designs and constructs buildings and machinery and sells equipment.